Na Li

Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II study

Bolin Chen, Qianzhi Wang, X. Pu, 2024, EClinicalMedicine.

First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study.

Y. Bai, Jufeng Wang, Shegan Gao, 2024, Nature medicine.